Ana Sayfa
Piyasalar
Grafikler ve Fikirler
Algo
Haberler
Store
Aracı Kurumlar
İndir
Ekonomik Takvim
Alım-Satım Sinyalleri
Web Terminali
Heatmap
Arama yapmak için
/
tuşuna basın: @kullanıcı, $sembol, ...
Ara
Giriş yap
Hesap oluştur
Türkçe
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
IMCR
#2129
Immunocore Holdings plc American Depositary Shares
31.690
0
USD
+0.70%
Sektör:
Sağlık Hizmetleri
Baz:
USD
Kar Para Birimi:
USD
Günlük Aralık
Yıllık Aralık
Günlük Değişim
+0.70%
Aylık Değişim
+4.38%
6 aylık değişim
-5.35%
Yıllık Değişim
-5.35%
Önceki Kapanış
31.470
0
Open
31.690
0
Bid
Ask
Low
31.690
0
High
31.690
0
Hacim
87
Piyasalar
ABD Borsası
Sağlık Hizmetleri
IMCR
Open full chart
Financials
Overview
Rapor
Statistics
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
31.78 M
43.86 M
48.09 M
49.82 M
50.07 M
50.7 M
—
Valuation ratios
Enterprise value
—
1.5 B
2.67 B
3.26 B
1.45 B
1.73 B
6.48 B
Price to earnings ratio
—
—
—
-63.4
-28.92
-48.89
-260.07
Price to sales ratio
—
—
—
14.04
4.75
4.37
18.28
Price to cash flow ratio
—
—
—
1 191.29
56.59
-163.13
166.22
Price to book ratio
—
—
—
9.5
4.09
4.59
7.89
Enterprise value to EBITDA ratio
—
—
—
-56.28
-15.41
-30.58
-111.72
Profitability ratios
Return on assets %
—
—
—
-0.09
-0.05
-0.03
-0.03
Return on equity %
—
—
—
-0.15
-0.14
-0.09
-0.09
Return on invested capital %
—
—
—
-126.09
-131.84
-133.03
-90.5
Gross margin %
—
—
—
99.58
99.12
98.73
394.97
Operating margin %
—
—
—
-23.91
-22.71
-11.34
-44.8
EBITDA margin %
—
—
—
-22.27
-21.36
-10.56
-41.52
Net margin %
—
—
—
-22.17
-16.47
-8.88
-34.11
Liquidity ratios
Quick ratio
—
—
—
3.77
4.36
4.01
22.16
Current ratio
—
—
—
3.8
4.38
4.04
22.3
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
—
—
—
0.42
0.39
0.39
0.38
Solvency ratios
Debt to assets ratio
—
—
—
0.23
0.43
0.41
1.63
Debt to equity ratio
—
—
—
0.37
1.2
1.15
4.52
Long term debt to total assets ratio
—
—
—
0.17
0.39
0.37
1.47
Long term debt to total equity ratio
—
—
—
0.27
1.08
1.03
4.07
Per share metrics
Operating cash flow per share
—
—
—
0.06
0.52
-0.21
-0.21
EBIT per share
—
—
—
-1.22
-1.41
-0.9
-0.9
EBITDA per share
—
—
—
-1.14
-1.33
-0.84
-0.83
Total debt per share
—
—
—
2.78
8.66
8.67
34.35
Cash per share
—
—
—
9.05
16.41
17.16
68.53
Net current asset value per share
—
—
—
10.82
18.6
19.8
78.28
Tangible book value per share
—
—
—
7.54
7.22
7.57
30.45
Working capital per share
—
—
—
7.97
14.36
14.9
63.75
Book value per share
—
—
—
7.54
7.22
7.57
30.45
Immunocore Holdings plc - American Depositary Shares
Immunocore is a global commercial-stage biotechnology company, based in Oxfordshire, which researches and develops biological drugs using soluble T-cell receptor technology.
Haberler
Ideaya Biosciences Surges On Promising Results For Hard-To-Treat Melanoma
Jefferies, rakip verisi öncesi Immunocore hissesi için Tut tavsiyesini korudu
Jefferies, gelir endişeleriyle Immunocore hissesini düşürdü
Jefferies downgrades Immunocore stock rating on revenue concerns
Immunocore Leerink Konferansı: Stratejik Büyüme ve İnovasyon
Immunocore at Leerink Conference: Strategic Growth and Innovation
Immunocore Holdings plc 2025 Q4 - Results - Earnings Call Presentation (NASDAQ:IMCR) 2026-02-25
Immunocore Holdings plc (IMCR) Q4 2025 Earnings Call Transcript
Immunocore Holdings kazancı $0,40 ile beklentilere göre daha kötü, kâr ise beklentilere göre düşük
Immunocore Holdings earnings missed by $0.40, revenue fell short of estimates
JAZZ Stock Rises as Q4 Earnings & Sales Top Expectations
RXRX Q4 Loss Narrower Than Expected, Revenues Increase Y/Y, Stock Up